Picture of Vyant Bio logo

VYNT — Vyant Bio News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Cancer Genetics To Delay Filing Of Its Annual Report

March 30 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * TO DELAY FILING OF ITS ANNUAL REPORT ON FORM 10-K FOR YEAR
ENDED
DECEMBER 31, 2019 DUE TO CIRCUMSTANCES RELATED TO COVID-19
    * COULD DELAY FUTURE PROJECTS FROM COMMENCING DUE TO
COVID-19
RELATED IMPACTS ON THE DEMAND FOR OUR SERVICES
    * IT IS NOT POSSIBLE AT THIS TIME TO ESTIMATE THE IMPACT
THAT
COVID-19 COULD HAVE ON OUR BUSINESS
    * MAY CONTINUE TO HAVE ADVERSE IMPACT ON GLOBAL ECONOMIC
CONDITIONS WHICH COULD HAVE ADVERSE EFFECT ON BUSINESS &
FINANCIAL CONDITION

Source text: https://bit.ly/3ax0maj
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vyant Bio

See all news